Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Vedolizumab as a Novel Treatment for Refractory Collagenous Colitis: A Case Report

Cushing, Kelly C, MD1; Mino-Kenudson, Mari, MD, PhD2; Garber, John, MD1; Lochhead, Paul, MBCh, PhD3; Khalili, Hamed, MD, MPH1

American Journal of Gastroenterology: April 2018 - Volume 113 - Issue 4 - p 632–633
doi: 10.1038/ajg.2018.7
LETTERS TO THE EDITOR
Buy

1Division of Gastroenterology, Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts, USA

2Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA

3Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA

Correspondence: Kelly C. Cushing, Division of Gastroenterology, Crohn's and Colitis Center, Massachusetts General Hospital, 165 Cambridge St, 9th Floor Boston, MA 02114, Massachusetts, USA. E-mail: kccushing@mgh.harvard.edu

© The American College of Gastroenterology 2018. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website